IP Library Granted Patent US 9,315,830
Granted Patent B2
US 9,315,830 · App. 14/608,132 · Granted Apr 19, 2016

Method of producing a recombinant microorganism

Inventors: David Jeffrey Fraser Walker (Amherst, MA); Michael Koepke (Skokie, IL)
Assignee: LanzaTech New Zealand Limited
C12N15/902
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,315,830
App. No.
14/608,132
Granted
Apr 19, 2016
Kind
B2
Abstract

The invention provides a genetic tool to insert, replace, delete, or otherwise manipulate a nucleic acid sequence in a microorganism to produce a recombinant microorganism. Notably, the invention makes use of homologous recombination, a type of genetic recombination in which nucleotide sequences are exchanged between two similar or identical molecules of DNA. Since the invention involves three homologous recombination events, it is referred to as a “triple cross” method.

Claims (22)

1. A method of producing a recombinant microorganism, comprising:

(a) providing a microorganism comprising a genetic element comprising target nucleic acid T1, a target nucleic acid T2, and a target nucleic acid T3,

(b) providing a DNA construct comprising a left homology arm LHA1 homologous to T1, a right homology arm RHA1 homologous to T2, and a right homology arm RHA2 homologous to T3, wherein RHA2 is located between LHA1 and RHA1,

(c) allowing the genetic element of (a) to undergo homologous recombination with the DNA construct of (b), whereby T1 aligns with LHA1 and T2 aligns with RHA1 to insert the portion of the DNA construct between LHA1 and RHA1, including RHA2, into the genetic element between T1 and T2, and

(d) allowing the genetic element of (c) to undergo self-homologous recombination, whereby T3 aligns with RHA2 to remove the portion of the genetic element between T3 and RHA2.

2. The method of claim 1 , wherein the genetic element of (a) comprises 5′-T3-T1-T2-3′; the DNA construct of (b) comprises 5′-LHA1-RHA2-RHA1-3′; a microorganism comprising a genetic element comprising 5′-T3-T1-RHA2-T2-3′ is formed in (and a microorganism comprising a genetic element comprising 5′-T3-T2-3′ is formed in (d) such that T1 is deleted from the genetic element.

3. The method of claim 1 , wherein the genetic element of (a) comprises 5′-T3-T1-T2-3′; the DNA construct of (b) comprises 5′-LHA1-RHA2-IS1-RHA1-3′ wherein IS1 is an insertion nucleic acid; a microorganism comprising a genetic element comprising 5′-T3-T1-RHA2-IS1-T2-3′ is formed in (c); and a microorganism comprising a genetic element comprising 5′-T3-IS1-T2-3′ is formed in (d), such that T1 is replaced IS1 in the genetic, element.

4. The method of claim 1 , wherein the genetic element of (a) comprises 5′-T1 T3 -3-T4-T2-3′ wherein T1 encompasses T3 and T4 is a target nucleic acid; the DNA construct of (b) comprises 5′-LHA1 RHA2 -RHA2-RHA1-3 wherein LHA1 encompasses RHA2; a microorganism comprising a genetic element comprising 5′-T1 T3 -RHA2-T2-3′ is formed in (c); and a microorganism comprising a genetic element comprising 5′-T1 T3 -T2-3′ is formed in (d), such that T4 is deleted from the genetic element.

5. The method of claim 1 , wherein the genetic element of (a) comprises 5′-T1 T3 -T2-3′ wherein T1 encompasses T3; the DNA construct of (b) comprises 5′-LHA1 RHA2 -RHA2-IS1-RHA1-3′ wherein LHA1 encompasses RHA2 and IS1 is an insertion nucleic acid; a microorganism comprising a genetic element comprising 5′-T1 T3 -RHA2-IS1-T2-3′ is formed in (c); and a microorganism comprising a genetic element comprising 5′-T1 T3 -IS1-T2-3′ is formed in (d), such that IS 1 is inserted in the genetic element.

6. The method of claim 1 , wherein the genetic element of (a) comprises 5′-T1 T3 -T4-T2-3′ wherein T1 encompasses T3 and T4 is a target nucleic acid; the DNA construct of (b) comprises 5′-LHA1 RHA2 -RHA2-IS1-RHA1-3 wherein LHA1 encompasses RHA2 and IS1 is an insertion nucleic acid; a microorganism comprising a genetic element comprising 5′-T1 T3 -RHA2-IS1-T2-3′ is formed in (c); and a microorganism comprising a genetic element comprising 5′-T1 T3 -IS1-T2-3′ is formed in (d), such that T4 is replaced by IS1 in the genetic element.

7. The method of claim 1 , wherein the DNA construct of (b) further comprises a counter selection marker CS1 upstream of LHA1 and a positive selection marker PS1 and a counter selection marker CS2 between LHA1 and RHA2.

8. The method of claim 7 , wherein (c) is followed by a step of selecting for expression of PS1 and against expression of CS1 and (d) is followed by a step of selecting against expression of CS2.

9. The method of claim 7 , wherein CS1 and CS2 are independently selected from the group consisting of pheS*, upp, sacB, tetAR, thyA, ccdB, lacY, rpsL, codA, pyrE, HSTK (thiK) gatA-1, and mazF; and PS1 is selected from the group consisting of catP, tetA(C), tetM, aad9, aadA, aadA2, and ermB.

10. The method of claim 1 , wherein the DNA construct of (b) further comprises a counter selection marker CS1 upstream of LHA1 and a positive selection marker PS1 between LHA1 and RHA2.

11. The method of claim 10 , wherein is followed by a step of selecting for expression of PS1 and against expression of CS1.

12. The method of claim 10 , wherein CS1 is selected from the group consisting of pheS*, upp, sacB, tetAR, thyA, ccdB, lacY, rpsL, codA, pyrE, HSTK (thiK), gatA-1, and mazF; and PS1 is selected from the group consisting of catP, tetA(C), tetM, aad9, aadA, aadA2, and ermB.

13. The method of claim 1 , wherein LHA1 is longer than RHA2.

14. The method of claim 13 , wherein LHA1 is equal to or greater than about 1000 base pairs in length and RHA2 is equal to or less than about 300 base pairs in length.

15. The method of claim 1 , wherein LHA1 and RHA1 are each longer than RHA2.

16. The method of claim 15 , wherein LHA1 and RHA1 are each equal to or greater than about 1000 base pairs in length and RHA2 is equal to or less than about 300 base pairs in length.

17. The method of claim 1 , wherein the microorganism is a bacterium, archea, virus, or fungus.

18. The method of claim 1 , wherein the microorganism belongs to genus Clostridium, Acetobacterium, Moorella, Butyribacterium, Blautia, Oxobacter, Thermoanaerobacter, Escherichia, Klebsiella, Zymomonas, Citrobacter, Enterobacter, Salmonella, Serratia, Lactobacillus, Lactococcus, Enterococcus, Pediococcus, Streptococcus, Saccharomyces, Pichia, Candida Hansenula, Yarrowia, Rhodotorula, Rhizopus, Trichosporon, Lipomyces, Aspergillus, trichoderma, Exophila, Mucor, Cladosporium, Phanerochaete, Cladiophilalophora, Paecilomyces, Scedosporium, Ophistoma, Bacillus, Oligotropha, Pseudomonas, Carbophilus, Hydrogenophaga, Mycobacterium, Zavarzinia, Cupravidus, Senechocystis, Chloroflexus, Methylomonas, Methylobacter, Methylococcus, Methylomicrobium, Methylosphera, Methylocaldum, Methylocystis, Methylosinus, Methanobacterium, Methanococcus, Methanogenium, Methanosarcina, Methanoshera, Methanothermobacter, Methanotrix, Corynebacterium, Acinetobacter, Actinomyces, Bacteroides, Burkholderia, Brevibacterium, Pyrococcus, Geobacter, Geobacillus, Paenibacillus, Mycobacterium, Rhodopseudomonas, Thermatoga, Thermoanaerobacter, Streptomyces, Rhodobacter, Rhodococcus, Peptococcus, Bifidobacterium, Propionibacterium, Fusobacterium, Campylobacter, Veillonella, Aquincola, Arthrobacter, Moraxella , or Psychrobacter.

Assignments (5)
CORRECTIVE ASSIGNMENT TO CORRECT THE THE PATENT NUMBE 9,5348,20 PREVIOUSLY RECORDED AT REEL: 059911 FRAME: 0400. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Aug 4, 2022
From: LANZATECH NEW ZEALAND LIMITED
To: LANZATECH NZ INC.
Reel/Frame 061084/0646 →
CORRECTIVE ASSIGNMENT TO CORRECT THE U.S. PATENT NUMBER 8,979,228 PREVIOUSLY RECORDED AT REEL: 059911 FRAME: 0400. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Aug 3, 2022
From: LANZATECH NEW ZEALAND LIMITED
To: LANZATECH NZ, INC.
Reel/Frame 061058/0076 →
CHANGE OF NAME Recorded May 9, 2022
From: LANZATECH NEW ZEALAND LIMITED
To: LANZATECH NZ, INC.
Reel/Frame 059911/0400 →
RELEASE OF SECURITY INTEREST Recorded May 9, 2022
From: VENTURE LENDING & LEASING VII, INC.; VENTURE LENDING & LEASING VIII, INC.
To: LANZATECH NEW ZEALAND LIMITED; LANZATECH, INC.; LANZATECH FREEDOM PINES BIOREFINERY LLC; LANZATECH HONG KONG LIMITED; LANZATECH PRIVATE LIMITED; LANZATECH UK LIMITED
Reel/Frame 059910/0789 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 2, 2015
From: WALKER, DAVID JEFFREY FRASER; KOEPKE, MICHAEL
To: LANZATECH NEW ZEALAND LIMITED
Reel/Frame 035070/0622 →
Continuity (2)
Provisional Application 61932737 · Jan 28, 2014
Related Publication 20150211022A1 · Jul 30, 2015